[Coronary artery disease: when to withhold a decision and call in the Heart Team? Almost every time]

Lucia Torracca1

  • 1U.O. Cardiochirurgia, Humanitas Research Hospital, Rozzano (MI).

Giornale Italiano Di Cardiologia (2006)
|December 7, 2018
PubMed

Insights

Multidisciplinary discussions, or Heart Team meetings, are crucial for tailoring coronary artery disease (CAD) treatments. This approach ensures optimal patient care by considering individual needs beyond clinical trial data.

Area of Science:

  • Cardiology
  • Clinical Practice Guidelines
  • Health Services Research

Background:

  • Multidisciplinary discussions are established in medicine but underutilized for coronary artery disease (CAD) patient treatment.
  • International guidelines recommend this approach, yet overtreatment and undertreatment persist in various CAD patient groups.
  • Evidence from trials and registries has limited generalizability to routine practice due to selected populations.

Purpose of the Study:

  • To emphasize the necessity of multidisciplinary discussion for optimizing coronary artery disease (CAD) patient care.
  • To highlight the limitations of applying clinical trial data directly to elderly CAD patients with comorbidities.
  • To advocate for the Heart Team approach in selecting individualized treatment strategies.

Main Methods:

  • Review of existing literature, including randomized trials, meta-analyses, and registries concerning CAD treatment.
  • Analysis of the challenges in applying evidence-based medicine to complex patient populations.
  • Conceptual framework emphasizing the role of interdisciplinary collaboration.

Main Results:

  • Clinical trial data is often not directly applicable to the heterogeneous and elderly CAD patient population.
  • Lack of universal application of multidisciplinary discussions leads to suboptimal treatment outcomes.
  • The Heart Team approach facilitates personalized treatment selection.

Conclusions:

  • Multidisciplinary discussion is essential for effective coronary artery disease (CAD) management.
  • The Heart Team model overcomes limitations of generalized treatment guidelines and trial data.
  • Individualized treatment selection through expert collaboration improves patient outcomes in CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
270
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
689
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.8K